It was shown that chordoma cells are characterized by a frequent loss of CDKN2A, resulting in activation of the CDK4/6 and RB pathways as shown by the expression of CDK4/6/pRb (S780) [25]. The gene discussed is CDKN2A; the disease is chordoma.